Genetic Variation at the ACE Gene Is Associated With Persistent Microalbuminuria and Severe Nephropathy in Type 1 Diabetes
Authors:
- Andrew D. PatersonAPAndrew D. Paterson
- Stephen W. SchererSSStephen W. Scherer
- the DCCT/EDIC Research GroupTGthe DCCT/EDIC Research Group
- 1 April 2005
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 54 (4) , 1238-1244
Abstract
The development and progression of microvascular complications have been extensively documented in a cohort of type 1 diabetic subjects enrolled in the Diabetes Control and Complications Trial (DCCT) and followed in the Epidemiology of Diabetes Interventions and Complications (EDIC) study. We describe the association of genetic variation in the ACE gene in 1,365 DCCT/EDIC subjects with incident persistent microalbuminuria (n = 312) and severe nephropathy (n = 115). We studied three markers (rs1800764, insertion/deletion, and rs9896208) in the ACE gene that allowed us to capture genetic variation in the common haplotypes occurring at frequencies of >5% in Caucasians. Compared with the more frequent genotype (D/I) for the insertion/deletion polymorphism, in multivariate models, the I/I genotype conferred a lower risk for persistent microalbuminuria (hazard ratio [HR] 0.62 [95% CI 0.43–0.89], P = 0.009) and severe nephropathy (0.56 [0.32–0.96], P = 0.033). Variation at the two other markers, rs1800764 and rs9896208, were also associated with these renal outcomes. In addition, homozygosity for the common haplotype TIC (which corresponded to the T, insertion, and C alleles at the three markers, rs1800764, insertion/deletion, and rs9896208, respectively) versus the CDT/TIC haplotype pair was associated with lower risk for development of persistent microalbuminuria (HR 0.49 [0.32–0.75], P = 0.0009) and severe nephropathy (0.41 [0.22–0.78], P = 0.006). Our findings in the DCCT/EDIC cohort provide strong evidence that genetic variation at the ACE gene is associated with the development of nephropathy in patients with type 1 diabetes.Keywords
This publication has 28 references indexed in Scilit:
- High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activityEuropean Journal of Human Genetics, 2002
- Meta analysis. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme geneNephrology Dialysis Transplantation, 1998
- Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research GroupDiabetes, 1997
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.Journal of Clinical Investigation, 1997
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Is diabetic nephropathy an inherited complication?Kidney International, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Familial Clustering of Diabetic Kidney DiseaseNew England Journal of Medicine, 1989
- The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research GroupDiabetes, 1986
- The changing natural history of nephropathy in type I DiabetesThe American Journal of Medicine, 1985